Abingworth LLP Portfolio Holdings

Abingworth LLP

$301 Million
Q4 2022

Abingworth LLP has filed its 13F form on February 10, 2023 for Q4 2022 where it was disclosed a total value porftolio of $301 Million distributed in 19 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vaxcyte, Inc. with a value of $96.8M, Verona Pharma PLC with a value of $64.2M, Vera Therapeutics, Inc. with a value of $57.3M, Hille Vax, Inc. with a value of $30.8M, and Adicet Bio, Inc. with a value of $18.9M.

Examining the 13F form we can see an increase of $8.99M in the current position value, from $292M to 301M.

Abingworth LLP is based out at London, X0

Below you can find more details about Abingworth LLP portfolio as well as his latest detailed transactions.

Portfolio value $301 Million

Healthcare: $301 Million

Stock Holdings Table Companies Only

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
PCVX Vaxcyte, Inc. Healthcare	$5.13B	$96.8 Million 32.11% of portfolio	2,019,057	Q4 2022 Reduced 51.57%
VRNA Verona Pharma PLC Healthcare	$2.56B	$64.2 Million 21.3% of portfolio	2,457,500	Q2 2022 Added 0.0%
VERA Vera Therapeutics, Inc. Healthcare	$1.15B	$57.3 Million 19.0% of portfolio	2,960,231	Q2 2021 New
HLVX Hille Vax, Inc. Healthcare	$62.2M	$30.8 Million 10.2% of portfolio	1,838,486	Q2 2022 New
ACET Adicet Bio, Inc. Healthcare	$36.4M	$18.9 Million 6.27% of portfolio	2,115,385	Q4 2021 Added 30.95%
PHAT Phathom Pharmaceuticals, Inc. Healthcare	$292M	$16.1 Million 5.34% of portfolio	1,435,106	Q1 2022 Added 19.28%
RPHM Reneo Pharmaceuticals, Inc. Healthcare	$41.1M	$4.83 Million 1.6% of portfolio	2,073,957	Q3 2021 Added 5.69%
JSPR Jasper Therapeutics, Inc. Healthcare	$800M	$2.7 Million 0.9% of portfolio	5,628,558	Q3 2021 New
NCNA Nu Cana PLC Healthcare	$63.2M	$2.2 Million 0.73% of portfolio	3,333,333	Q3 2020 New
EFTR E Ffector Therapeutics, Inc. Healthcare	$0	$2.07 Million 0.69% of portfolio	4,822,114	Q3 2021 New
PRTK Paratek Pharmaceuticals, Inc. Healthcare	$0	$1.95 Million 0.65% of portfolio	1,041,131	Q3 2017 New
SPRB Spruce Biosciences, Inc. Healthcare	$9.42M	$1.97 Million 0.65% of portfolio	1,792,518	Q3 2022 New
CBAY Cyma Bay Therapeutics, Inc. Healthcare	$0	$821,000 0.27% of portfolio	131,036	Q4 2018 Reduced 52.07%
SIEN Sientra, Inc. Healthcare	$4.62M	$334,000 0.11% of portfolio	1,673,589	Q2 2022 Reduced 28.78%
XCUR Exicure, Inc. Healthcare	$92.7M	$323,000 0.11% of portfolio	281,636	Q3 2022 New
AGLE Aeglea Bio Therapeutics, Inc. Healthcare	$1.69B	$108,000 0.04% of portfolio	240,500	Q1 2019 New
MTEM Molecular Templates, Inc. Healthcare	$10.1M	$66,000 0.02% of portfolio	200,000	Q4 2019 New
OBSV Obs Eva Sa Healthcare	$0	$12,000 0.0% of portfolio	87,999	Q1 2019 Reduced 80.0%

Summary

Portfolio
No. of Stocks 19
Current Value $301 Million
Prior Value $292 Million
Filing
Period Q4 2022
Filing Date February 10, 2023
Form Type 13F-HR
Activity in Q4 2022
New Purchases 0 stocks
Additional Purchases 0 stocks
Sold out of 0 stocks
Reduced holdings in 1 stocks

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abingworth LLP, based on Form 13F filings with the SEC.

News

Stay updated on Abingworth LLP with notifications on news.

Account